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Abstract
Chronic obstructive pulmonary disease (COPD) is a common cause of morbidity in the UK and is
increasingly seen in elderly patients, often requiring multiple courses of steroids. We present a case
of a 72 year old lady with repeated exacerbations of COPD which did not respond to conventional
treatment. Herpes simplex virus (HSV1) tracheobronchitis was diagnosed following a rigid
bronchoscopy and her symptoms improved with intravenous acyclovir. This is the first published
case of HSV tracheitis in a non immunosuppressed individual with chronic lung disease.
Background
Herpes simplex virus (HSV1) infection may be considered
in the differential diagnosis of patients with chronic lung
disease not responding to conventional treatment. This
infection is a rare, but potentially treatable, cause of exac-
erbations in such patients. Appropriate diagnostic studies
should be performed to confirm the diagnosis and initiate
therapy accordingly. Studies have documented a signifi-
cant mortality related to herpes infection and a raised
awareness of this condition is important to improve out-
come in these patients [1,2].
We present a case of a 72 year old lady with repeated exac-
erbations of COPD which did not respond to conven-
tional treatment.
Case Presentation
A 72 year old lady, with known chronic obstructive pul-
monary disease (COPD), was seen in the outpatient
department with a six month history of progressive short-
ness of breath. Over this time she had suffered four exac-
erbations, requiring steroids and antibiotics, but no
hospital admission. Previously her symptoms had been
controlled with inhaled steroids, bronchodilators and as
required home nebulisers. She also reported several epi-
sodes of streaky haemoptysis but there was no history of
weight loss.
Two years previously she had suffered a myocardial infarc-
tion resulting in mildly impaired left ventricular function;
there was no history of any HSV infection. She was an ex-
smoker with a 50 pack year history. Medication included
Tiotropium 18 micrograms od, Seretide 250 ii bd and Bry-
canyl inhalers, as required Salbutamol nebulisers, Monte-
leukast 10 mg od, Valsartan 80 mg od, Clopidogrel 75 mg
od, Fluoxetine 20 mg od, Prednisolone 10 mg od and
Ezetimibe 5 mg od.
Examination revealed widespread expiratory wheezing,
there was no evidence of oral HSV; the remaining exami-
nation was unremarkable. Chest radiograph and baseline
blood tests were all normal; her spirometry had remained
stable over the last year FEV1 0.85 l/min, FVC 1.15 l/min.
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Fibre-optic bronchoscopy was performed because of the
haemoptysis. This showed widespread inflammation of
the endobronchial tree with nodules throughout the
mucosa of the trachea and both main bronchi. Bronchial
washings, brushings and biopsies, showed active chronic
inflammation with no malignant cells identified.
Subsequently, due to an acute deterioration in symptoms,
she was admitted with an infective exacerbation of COPD.
Despite treatment, her symptoms continued to deteriorate
and she developed an inspiratory stridor. High resolution
computerised tomography of her thorax showed a nar-
rowing in the left main bronchus, with no lymphadenop-
athy. A repeat bronchoscopy was unchanged revealing
widespread mucosal abnormality, with a nodular appear-
ance. Copious mucus plugging was seen and cultures of
the secretions isolated pseudomonas aeruginosa. She was
commenced on intravenous Ceftazadime with little
improvement.
Further investigations, including immunoglobulins, com-
plement, specific antibody levels and a vasculitis screen
were all normal. Repeat bronchoalveolar lavage (BAL)
was inconclusive and viral cultures of BAL samples were
negative.
A rigid bronchoscopy, performed to obtain a larger biopsy
sample, revealed partial stenosis and irregularity of the
main bronchi. Histological examination showed foci of
ulceration with multi-nuclear cells and grand blast intra-
nuclear viral inclusions peripherally, suggestive of her-
petic infection. Immunohistochemistry confirmed the
presence of herpes simplex and PCR for HSV1 was also
positive.
She was reviewed by the immunologist who found no
immune deficiency. After two weeks on intravenous acy-
clovir (5 mg per kg tds), her symptoms improved and she
was discharged home.
Following discharge, repeat bronchoscopies have shown
significant improvement of the abnormal mucosa and
nodularity. A CT bronchoscopy was also performed which
demonstrated persistent narrowing of her left main bron-
chus. Subsequent to her treatment with intravenous acy-
clovir, she underwent two further admissions with
episodes of dyspnoea and mild stridor. These responded
to further courses of intravenous acyclovir and antibiotics.
It was therefore decided to commence maintenance acy-
clovir 400 mg bd initially then 200 mg bd after six
months. She has remained well on this and has only
required one admission for an exacerbation in the follow-
ing two years.
Discussion
This is the first published case of herpes simplex tracheitis
in the non-immunocompromised patient with chronic
lung disease. It has however, been suggested that herpetic
respiratory infections are commoner in patients with
underlying lung disease [3]. HSV causes a latent infection
resulting in a potential for recurrence particularly in the
elderly or immunosuppressed. In this case, repeated
courses of steroids for COPD exacerbations and low dose
maintenance prednisolone, were thought to have made
the patient more susceptible to viral infections however,
formal immunological tests were normal.
Lower respiratory tract HSV infections have been reported
in newborn infants, patients with burns, patients with
Acquired Immunodeficiency Syndrome (AIDS) and those
who have been intubated [1,2,4-6].
The virus source is usually from the oropharynx. Several
patterns of pulmonary damage can occur, with tracheo-
bronchitis the most common manifestation. Ulceration
of the trachea may be associated with necrotizing pneu-
monia. The surface of the ulcerated area is covered with a
fibrinopurulent exudate containing necrotic cells, nuclear
debris, fibrin and inflammatory cells. The histological
appearances are often attributed to a bacterial infection
with viral infection not being suspected [4].
Isolation of the virus from respiratory secretions alone
does not confirm the diagnosis, as 1–5% of the popula-
tion excretes herpes virus in the oropharynx without
symptoms [4]. Diagnosis is best made in combination
with viral culture, PCR and the presence of characteristic
features (intra nuclear inclusions) demonstrated on his-
tology.
Patients with herpes infection of the respiratory tract may
develop severe airway obstruction and present with stri-
dor. This occurs due to necrosis of large amounts of epi-
thelium resulting in a thick pseudo membrane. Tracheal
dilation and sequential bronchoscopic excisions of granu-
lation tissue are required to relieve the obstruction [4,5,7-
9].
Conclusion
Many patients in the UK are exposed to HSV and its role
in difficult to treat exacerbations of COPD may be under-
estimated. Diagnosis may be considered in patients with
chronic lung disease, especially during exacerbations of
COPD who are not responding to conventional treat-
ment. It should also be considered in elderly patients,
those who are difficult to wean from ventilation and in
the immunocompromised [6,9,10].Publish with BioMed Central    and   every 
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Appropriate diagnostic studies should be undertaken and
documented isolation of HSV1 obtained before appropri-
ate treatment is commenced. Studies have documented a
significant mortality related to HSV infection and a raised
awareness of this condition is important to improve the
outcome in these patients [1,2].
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